Smith & Nephew PLC
LSE:SN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Smith & Nephew PLC
LSE:SN
|
UK |
|
Allogene Therapeutics Inc
NASDAQ:ALLO
|
US |
|
T
|
TC Energy Corp
XMUN:TRS
|
CA |
Wall St Price Targets
SN Price Targets Summary
Smith & Nephew PLC
According to Wall Street analysts, the average 1-year price target for
SN is 1 298.97 GBX with a low forecast of 1 060.5 GBX and a high forecast of 1 627.5 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SN's stock price target?
Price Target
1 298.97
GBX
According to Wall Street analysts, the average 1-year price target for
SN is 1 298.97 GBX with a low forecast of 1 060.5 GBX and a high forecast of 1 627.5 GBX.
What is the Revenue forecast for Smith & Nephew PLC?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 6%.
What is the Gross Profit forecast for Smith & Nephew PLC?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Smith & Nephew PLC?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 5 years is 12%.
What is the Pre-Tax Income forecast for Smith & Nephew PLC?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 22%.
What is the Net Income forecast for Smith & Nephew PLC?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 5 years is 18%.